Antitumor Molecular-targeted Agents

TCI presents Antitumor Molecular-targeted agents functioning as targeted kinase inhibitor. They have an improved side effect profiles and are less hazardous than previous tubulin inhibitors.

Since its foundation in 1946, TCI’s philosophy has been to contribute to society through the manufacturing and supply of organic laboratory chemicals. We are proud, that today our company offers more than 30,000 quality reagents on a global basis. In recent years, our business has also expanded to the manufacturing of fine chemicals such as pharmaceutical and cosmetic raw materials, electroluminescent compounds, and building blocks for liquid crystals.

Antitumor agents are a class of pharmaceuticals that are currently deeply investigated. They prevent malignant cells from growing or induce their apoptosis. Many antitumor agents like cytotoxic tubulin inhibitors suffer from low specifity for their target.   

Here we present modern antitumor agents with improved specifity. For example there are targeted kinase inhibitors that have an improved side effect profile and pose less hazards than non-specific tubulin inhibitors.

For more information: Antitumor Molecular-targeted agents | Tokyo Chemical Industry UK Ltd. (tcichemicals.com)

Contact:

Tokyo Chemical Industry UK Ltd.
The Magdalen Centre
Robert Robinson Avenue
The Oxford Science Park,
Oxford OX4 4GA
Tel: 01865 784560
E-mail: Sales-UK@TCIchemicals.com

You can also contact our local sales representative Mr. Robbie Benning: Robbie.Benning@TCIchemicals.com